Paxil Birth Defect Lawyers Say $2.5M Verdict The Tip Of The Iceberg
The recent $2.5 million birth defect verdict against GlaxoSmithKline (GSK) over Paxil use is very significant, according to legal experts, who say that this first verdict will absolutely affect other Paxil and Zoloft birth defect lawsuits. In fact, they say it's just the tip of the iceberg.
Larger verdicts expected
Bryan Aylstock, a Florida attorney whose practice represents parents and their children who have suffered birth defect injuries due to Paxil and Zoloft use, says that the first Paxil birth injury lawsuit verdict is very significant – especially because the $2.5 million Paxil verdict was awarded to the family of a child who had a heart defect, but not one that was specifically identified in any of the published studies. He provided some insight on the trial:
Expert testimony provided at trial led the jury to decide that Paxil can cause a constellation of birth defects. Glaxo defended by saying that unless it’s a specifically identified and increased risk based on one of the [published] studies, then the plaintiff should not be permitted to recover. However, the jury rejected that – and did so soundly.
I think the size of this verdict sent a message to Glaxo that they did do wrong and that they need to compensate these injured children so that they can have some semblance of a normal life. There’s a lot more cases coming down the pike, though, and many more verdicts to be had. I think the 2.5 million dollar [verdict] is just the tip of the iceberg. I predict there will be many other larger verdicts as the litigation unfolds.
Similar lawsuits filed against Pfizer over Zoloft
Aylstock and other Paxil and Zoloft birth defect attorneys say that a number of similar lawsuits have been filed against Pfizer regarding its antidepressant drug Zoloft (an SSRI, or selective serotonin reuptake inhibitor, drug) and its link to birth defects. Aylstock explained, “As new evidence emerges, lawsuits are being filed against Pfizer for Zoloft birth defects. None have progressed to the point of trial yet and it will be interesting to see how Pfizer defends its conduct in the Zoloft litigation.
The foregoing article has been prepared by an attorney who is a regular contributor to FreeAdvice, and is now undergoing review by the site's editorial staff.